title: Persistent lipid abnormalities in diabetes; are we approaching the treatment optimally?
authors: G A
authors: GA
authors: Hitman
mesh_terms: D000924:Anticholesteremic Agents / Q000009:adverse effects*; D002318:Cardiovascular Diseases / Q000209:etiology*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D003925:Diabetic Angiopathies / Q000209:etiology*; D050171:Dyslipidemias / Q000209:etiology*; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D008297:Male; D024821:Metabolic Syndrome / Q000150:complications*
chemical_list: D000924:Anticholesteremic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors